UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy

eLife, 2023-04, Vol.12

2023

Volltextzugriff (PDF)

Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells

The Journal of clinical investigation, 2009-05, Vol.119 (5), p.1109-1123

2009

Volltextzugriff (PDF)

Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia

Haematologica (Roma), 2017-03, Vol.102 (3), p.519-528

2017

Volltextzugriff (PDF)

IKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1

Blood, 2014-04, Vol.123 (15), p.2401-2411

2014

Volltextzugriff (PDF)

Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche

Blood, 2014-02, Vol.123 (9), p.1361-1371

2014

Volltextzugriff (PDF)

A Murine Model of CML Blast Crisis Induced by Cooperation between BCR/ABL and NUP98/HOXA9

Proceedings of the National Academy of Sciences - PNAS, 2002-05, Vol.99 (11), p.7622-7627

2002

Volltextzugriff (PDF)

Distinct graft-versus-leukemic stem cell effects of early or delayed donor leukocyte infusions in a mouse chronic myeloid leukemia model

Blood, 2012-01, Vol.119 (1), p.273-284

2012

Volltextzugriff (PDF)

Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1

Blood, 2016-04, Vol.127 (14), p.1803-1813

2016

Volltextzugriff (PDF)

The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues

Haematologica (Roma), 2011-04, Vol.96 (4), p.590-601

2011

Volltextzugriff (PDF)

Reversibility of acute B-cell leukaemia induced by BCR - ABL1

Nature genetics, 2000-01, Vol.24 (1), p.57-60

2000

Volltextzugriff (PDF)

Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms

Leukemia research, 2018-04, Vol.67, p.67-74

2018

Volltextzugriff (PDF)

Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era

Leukemia research, 2004-05, Vol.28, p.21-28

Van Etten, Richard A

2004

Volltextzugriff (PDF)

The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice

Blood, 2002-06, Vol.99 (12), p.4568-4577

2002

Volltextzugriff (PDF)

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

The Journal of experimental medicine, 1999-05, Vol.189 (9), p.1399-1412

1999

Volltextzugriff (PDF)

Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

Blood, 2012-09, Vol.120 (13), p.2573-2580

2012

Volltextzugriff (PDF)

The Src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia–like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase

Blood, 2001-01, Vol.97 (1), p.4-13

2001

Volltextzugriff (PDF)

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL

Blood, 2001-03, Vol.97 (5), p.1442-1450

2001

Volltextzugriff (PDF)

SHP2 is required for BCR-ABL1-induced hematologic neoplasia

Leukemia, 2018-01, Vol.32 (1), p.203-213

2018

Volltextzugriff (PDF)

Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models

Current opinion in hematology, 2001-07, Vol.8 (4), p.224-230

Van Etten, R A

2001

Volltextzugriff (PDF)

Blast Crisis in a Murine Model of Chronic Myelogenous Leukemia

Proceedings of the National Academy of Sciences - PNAS, 1991-12, Vol.88 (24), p.11335-11338

1991

Volltextzugriff (PDF)

The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase

Blood, 2000-07, Vol.96 (2), p.664-670

2000

Volltextzugriff (PDF)

Models of chronic myeloid leukemia

Current oncology reports, 2001-05, Vol.3 (3), p.228-237

Van Etten, R A

2001

Volltextzugriff (PDF)

v-abl Causes Hematopoietic Disease Distinct From That Caused by bcr-abl

Proceedings of the National Academy of Sciences - PNAS, 1991-08, Vol.88 (15), p.6506-6510

1991

Volltextzugriff (PDF)

Disease Progression in a Murine Model of bcr/abl Leukemogenesis

Leukemia & lymphoma, 1993, Vol.11 (s1), p.239-242

Van Etten, Richard A.

1993

Volltextzugriff (PDF)

The molecular pathogenesis of the Philadelphia-positive leukemias: implications for diagnosis and therapy

Cancer treatment and research, 1993, Vol.64, p.295

Van Etten, R A

1993

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

ThemaFusion Proteins, Bcr-Abl - Genetics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy

Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells

Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia

IKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1

Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche

A Murine Model of CML Blast Crisis Induced by Cooperation between BCR/ABL and NUP98/HOXA9

Distinct graft-versus-leukemic stem cell effects of early or delayed donor leukocyte infusions in a mouse chronic myeloid leukemia model

Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1

The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues

Reversibility of acute B-cell leukaemia induced by BCR - ABL1

Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms

Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era

The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation

The Src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia–like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL

SHP2 is required for BCR-ABL1-induced hematologic neoplasia

Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models

Blast Crisis in a Murine Model of Chronic Myelogenous Leukemia

The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase

Models of chronic myeloid leukemia

v-abl Causes Hematopoietic Disease Distinct From That Caused by bcr-abl

Disease Progression in a Murine Model of bcr/abl Leukemogenesis

The molecular pathogenesis of the Philadelphia-positive leukemias: implications for diagnosis and therapy

Aktive Filter

Suchergebnisse filtern